Watermark
Go to Asia edition

Deleveraging Sanofi trims syndicate for €3bn revolver

Sanofi-Aventis, the pharmaceutical firm, has managed to cut the size of the bank group on its new €3bn facility but demand for the A1/AA-/AA- rated company’s paper has meant that some banks have also joined the syndicate.

  • 25 Nov 2011
France’s Sanofi has cut back the size of its corporate line, replacing an outstanding €5.8bn revolver due to expire next year with a €3bn one year plus one plus one facility. The group’s vice-president of treasury finance, Olivier Klaric, had told EuroWeek that he would have been happy ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial
Log in

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
View full table
1 BNP Paribas 5,997 17 15.40
2 Citi 4,679 16 12.02
3 Lloyds Bank 3,158 6 8.11
4 Bank of America Merrill Lynch (BAML) 3,104 10 7.97
5 Morgan Stanley 3,066 8 7.88

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Citi 70,341.11 234 10.46%
2 JPMorgan 64,579.62 197 9.60%
3 Bank of America Merrill Lynch 51,474.08 169 7.65%
4 Wells Fargo Securities 51,322.59 157 7.63%
5 Credit Suisse 47,533.25 150 7.07%